-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Solriamfetol Hydrochloride in Attention Deficit Hyperactivity Disorder (ADHD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Solriamfetol Hydrochloride in Attention Deficit Hyperactivity Disorder (ADHD) Drug Details: Solriamfetol hydrochloride (Sunosi) was a phenylalanine...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pitolisant Hydrochloride in Prader-Willi Syndrome (PWS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pitolisant Hydrochloride in Prader-Willi Syndrome (PWS) Drug Details:Pitolisant hydrochloride (Wakix, Ozawade) is a central nervous system...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pitolisant Hydrochloride in Myotonic Dystrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Pitolisant Hydrochloride in Myotonic DystrophyDrug Details:Pitolisant hydrochloride (Wakix, Ozawade) is a central nervous system drug. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pitolisant Hydrochloride in Hypersomnia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pitolisant Hydrochloride in Hypersomnia Drug Details:Pitolisant hydrochloride (Wakix, Ozawade) is a central nervous system drug. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Acetazolamide + Dronabinol) in Obstructive Sleep Apnea
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Acetazolamide + Dronabinol) in Obstructive Sleep Apnea Drug Details:Fixed dose combination of acetazolamide and dronabinol (IHL-42X)Â is...
-
Product Insights
NewSleep Apnea Diagnostic Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Sleep Apnea Diagnostic Systems Pipeline Market Report Overview Sleep apnea diagnostic systems includes systems and devices used for the diagnosis of sleep apnea. The sleep apnea diagnostic systems pipeline report provides comprehensive information about the sleep apnea diagnostic systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·      Portable Polysomnography Systems Key Territories ·      The US ·      Europe ·      Israel ·      Japan...
-
Company Profile
![]()
Inspire Medical Systems Inc – Company Profile
Inspire Medical Systems Inc (Inspire Medical) is a medical technology company THAT focuses on the development of solutions for patients with obstructive sleep apnea (OSA). iT offers a neurostimulation technology that provides moderate to severe OSA treatment. Its platform includes inspire therapy system, inspire physician programmer and inspire cloud, among others. Inspire Medical also develops solutions to monitor a patient’s breathing and deliver mild hypoglossal nerve stimulation to maintain an open airway. The company participates in various clinical trials of...
Add to Basket -
Company Profile
![]()
RespireRx Pharmaceuticals Inc – Company Profile
RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc. involved in the discovery, development, and commercialization of innovative products for the treatment of various respiratory disorders (RD) and CNS problems. RespireRx focuses on attention deficit hyperactivity disorder, obstructive sleep apnea (OSA), spinal cord injury and other neurological disorders. The company's lead product is Dronabinol, an oral capsule drug product which is being evaluated for the treatment of OSA. The company's other pipeline products include CX1739, CX717, CX1942 and others. RespireRx is...
Add to Basket -
Company Insights
L’Oréal S.A. – Digital Transformation Strategies
L'Oréal S.A. – Digital Transformation Strategies Overview L'Oréal S.A. (L'Oréal) has been focusing on using mobile technologies, artificial intelligence and augmented reality to digitally transform its operations. The annual ICT spending of L'Oréal was estimated at $1 billion for 2022. A major share of this spending is earmarked for acquiring software, ICT services and hardware from vendors. L'Oréal is a multinational cosmetic firm that produces and markets a range of perfume, hair care, makeup, coloring, and skin care products. L'Oréal...
-
Company Profile
![]()
SciSparc Ltd – Company Profile
SciSparc Ltd (SciSparc), formerly Therapix Biosciences Ltd, is a clinical-stage biopharmaceutical company which focuses on the development of cannabinoid-based pharmaceuticals for the treatment of central nervous system disorders. SciSparc’s major product candidates include SCI-110, for the treatment of Tourette Syndrome (TS), Obstructive Sleep Apnea (OSA), and Alzheimer’s disease and agitation, SCI-210, for the treatment of Autism Spectrum Disorder (ASD) and epilepsy, and SCI-160, for the treatment of pain. The company conducts its clinical programs in collaboration with various pharma companies...
Add to Basket -
Product Insights
Inspire Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Inspire Medical Systems Inc (Inspire) is a medical technology company. It focuses on the development of solutions for patients with obstructive sleep apnea (OSA). The company offers a neurostimulation technology that provides moderate to severe OSA treatment. It also develops solutions to monitor a patient’s breathing and deliver mild hypoglossal nerve stimulation to maintain an open airway. Inspire participates in various clinical trials of products in the related sector. The company serves to healthcare professionals across the Asia Pacific, Europe...
-
Product Insights
![]()
Net Present Value Model: Wakix
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Wakix Drug Details Pitolisant hydrochloride (Wakix,...
-
Product Insights
![]()
Net Present Value Model: Sunosi
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Sunosi Drug Details Solriamfetol hydrochloride (Sunosi)...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (acetazolamide + dronabinol)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (acetazolamide + dronabinol) Drug Details Fixed dose combination of acetazolamide and dronabinol (IHL-42X)Â is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – dronabinol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry dronabinol Drug Details Dronabinol is under development for the treatment of obstructive sleep apnea...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – solriamfetol hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry solriamfetol hydrochloride Drug Details Solriamfetol hydrochloride (Sunosi) was a phenylalanine derivative, acts as an...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – pitolisant hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pitolisant hydrochloride Drug Details Pitolisant hydrochloride (Wakix, Ozawade) is a central nervous system drug....
-
Product Insights
Diagnostic and Measurement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Diagnostic and measurement devices include devices that are used to measure pressure, flow, and volume in a patient's airway and lungs. The category also covers devices used to measure oxygen saturation in the blood. The Diagnostic and Measurement Devices pipeline market research report provides comprehensive information about the image-guided surgery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M2 (CHRM2) is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, thalamus, lungs, and prostate. An increase in M2 receptors has been associated with depression. The CHRM2 pipeline market research report provides comprehensive information on the CHRM2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Minimally Invasive Surgical (MIS) Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022
Minimally invasive surgery (MIS) is a term used to describe either a smaller incision or an approach that does not involve cutting tendons or splitting muscles. The minimally invasive surgery (MIS) devices pipeline market research report provides comprehensive information about the MIS devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.